Dextech Medical AB (XSAT:DEX)

Dextech Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	10.12	14.71	19.04	25.24	35.47	3.46
Cash & Short-Term Investments	10.12	14.71	19.04	25.24	35.47	3.46
Cash Growth	-35.14%	-22.76%	-24.54%	-28.86%	926.20%	-43.25%
Other Receivables	-	0.09	0.13	0.11	0.2	0.03
Receivables	0.68	0.09	0.13	0.11	0.2	0.03
Other Current Assets	-	0.38	0.5	0.47	0.35	0.26
Total Current Assets	10.8	15.18	19.68	25.82	36.02	3.75
Long-Term Investments	0	0	0	0	0	0
Other Intangible Assets	9.88	0.25	0.25	0.25	0.39	0.54
Long-Term Deferred Charges	-	9.67	10.66	8.97	3.18	2.94
Total Assets	20.68	25.1	30.59	35.03	39.59	7.23

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	-	0.13	0.28	0.15	0.25	0.04
Accrued Expenses	-	0.18	0.69	0.55	0.43	0.15
Other Current Liabilities	0.54	0.02	0.01	0.02	0.03	0.03
Total Current Liabilities	0.54	0.34	0.98	0.72	0.71	0.22
Total Liabilities	0.54	0.34	0.98	0.72	0.71	0.22

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	20.14	0.83	0.83	0.83	0.83	0.67
Additional Paid-In Capital	-	105.2	105.2	105.2	105.2	68.22
Retained Earnings	-	-81.26	-76.42	-71.71	-67.15	-61.88
Shareholders' Equity	20.14	24.76	29.61	34.31	38.88	7.02
Total Liabilities & Equity	20.68	25.1	30.59	35.03	39.59	7.23

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Cash (Debt)	10.12	14.71	19.04	25.24	35.47	3.46
Net Cash Growth	-35.14%	-22.76%	-24.54%	-28.86%	926.20%	-43.25%
Net Cash Per Share	0.54	0.79	1.01	1.37	2.09	0.23
Filing Date Shares Outstanding	18.49	18.49	18.49	18.49	18.49	14.92
Total Common Shares Outstanding	18.49	18.49	18.49	18.49	18.49	14.92
Working Capital	10.26	14.85	18.7	25.1	35.31	3.54
Book Value Per Share	1.09	1.34	1.60	1.86	2.10	0.47
Tangible Book Value	10.26	24.51	29.36	34.07	38.49	6.47
Tangible Book Value Per Share	0.56	1.33	1.59	1.84	2.08	0.43

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error